ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.605
      -0.21%
      Bitcoin
      64,950.52
      -0.29%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ionis Pharmaceuticals Inc (IONS)

      7. Ionis Pharmaceuticals Inc (IONS) News

      IONS

      Ionis Pharmaceuticals (IONS)

      Ionis Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IONS
      DateTimeSourceHeadlineSymbolCompany
      11/17/20234:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      11/16/20238:00AMGlobeNewswire Inc.Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental EpilepsiesNASDAQ:IONSIonis Pharmaceuticals Inc
      11/15/20233:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      11/11/202311:30AMPR Newswire (US)Ionis shares positive clinical update from ongoing trial of ION582 for Angelman syndromeNASDAQ:IONSIonis Pharmaceuticals Inc
      11/09/202312:42PMPR Newswire (US)Ionis presents positive two-year results from the Phase 2 open label extension study of donidalorsen in patients with hereditary angioedemaNASDAQ:IONSIonis Pharmaceuticals Inc
      11/03/20237:05AMPR Newswire (US)Ionis to present at upcoming investor conferencesNASDAQ:IONSIonis Pharmaceuticals Inc
      11/02/20232:43PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IONSIonis Pharmaceuticals Inc
      11/02/202311:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IONSIonis Pharmaceuticals Inc
      11/02/20237:00AMPR Newswire (US)Ionis reports third quarter 2023 financial resultsNASDAQ:IONSIonis Pharmaceuticals Inc
      11/01/20235:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      10/19/20237:05AMPR Newswire (US)Ionis to hold third quarter 2023 financial results webcastNASDAQ:IONSIonis Pharmaceuticals Inc
      10/18/20236:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      10/16/20234:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      10/12/20232:54PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      10/12/20232:35PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      10/04/20237:00AMPR Newswire (US)Ionis shares significant business and pipeline progress at Innovation Day, highlighting strength of capabilities from research and technology through commercializationNASDAQ:IONSIonis Pharmaceuticals Inc
      10/02/20231:17PMGlobeNewswire Inc.Praxis Precision Medicines Provides Portfolio Update at 2023 R&D DayNASDAQ:IONSIonis Pharmaceuticals Inc
      09/29/20235:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/29/20234:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/28/20236:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/28/20236:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/28/202312:02PMPR Newswire (US)Eplontersen Phase 3 results published in JAMA show consistent and sustained benefitNASDAQ:IONSIonis Pharmaceuticals Inc
      09/27/20237:59AMDow Jones NewsIonis, Roche Set New Pact Targeting Alzheimer's, Huntington'sNASDAQ:IONSIonis Pharmaceuticals Inc
      09/27/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IONSIonis Pharmaceuticals Inc
      09/27/20237:00AMPR Newswire (US)Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer's disease and Huntington's diseaseNASDAQ:IONSIonis Pharmaceuticals Inc
      09/26/20236:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/26/20235:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/26/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IONSIonis Pharmaceuticals Inc
      09/26/20237:00AMPR Newswire (US)Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndromeNASDAQ:IONSIonis Pharmaceuticals Inc
      09/12/20237:05AMPR Newswire (US)Ionis to host investor and analyst day eventNASDAQ:IONSIonis Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IONS